Recently, we have demonstrated that Tregs of GvHD patients show a significant reduction of CCR5 and CXCR3 surface expression likely leading to a diminished migration capacity of Tregs with significantly lower Treg cell infiltration in the inflamed intestinal mucosa [28]. This evidence concerns the gene CXCR3 and graft versus host disease.